Abstract
We report an 11-year old female with myelodysplastic (refractory anemia with excess of blasts) presentation of Fanconi anemia. After failure of initial chemotherapy with low doses of 6-mercaptopurine and prednisolone she underwent allogeneic bone marrow transplantation (BMT) from her HLA-matched sibling. Busulfan 8 mg/kg and cyclophosphamide 40 mg/kg were used as conditioning. The post-transplant course was uneventful with fast trilineage engraftment and mild cutaneous acute GVHD. She is alive 17 months after BMT with full hematological reconstitution without evidence of MDS.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maschan, A., Kryzanovskii, O., Yourlova, M. et al. Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation. Bone Marrow Transplant 19, 385–387 (1997). https://doi.org/10.1038/sj.bmt.1700662
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700662
- Springer Nature Limited
Keywords
This article is cited by
-
Allogeneic stem cell transplantation in patients with Fanconi's anemia and myelodysplasia or leukemia utilizing low-dose cyclophosphamide and total body irradiation
Bone Marrow Transplantation (2004)
-
Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors
Bone Marrow Transplantation (2003)
-
The role of busulfan in bone marrow transplantation
Medical Oncology (1999)